Figure 3.

Differences in envisioned clinical practice using CP-GEP versus EORTC nomogram to predict risk of recurrence. For the application of the CP-GEP model, only tissue from the (already excised) primary melanoma is needed (in combination with Breslow depth in mm and patients’ age at diagnosis). For the EORTC nomogram, an SLNB is required. CP-GEP, clinicopathologic and gene expression profile; EORTC, European Organization for Research and Treatment of Cancer; FFPE, formalin-fixed paraffin-embedded; SLNB, sentinel lymph node biopsy; SN, sentinel node.